Page last updated: 2024-10-21

pd 173074 and Invasiveness, Neoplasm

pd 173074 has been researched along with Invasiveness, Neoplasm in 3 studies

Research Excerpts

ExcerptRelevanceReference
"To validate this model in primary human pituitary tumors, we examined the expression of ptd-FGFR4, N-cadherin, and clinical behavior."1.33Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications. ( Asa, SL; Ezzat, S; Winer, D; Zheng, L, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qian, X1
Anzovino, A1
Kim, S1
Suyama, K1
Yao, J1
Hulit, J1
Agiostratidou, G1
Chandiramani, N1
McDaid, HM1
Nagi, C1
Cohen, HW1
Phillips, GR1
Norton, L1
Hazan, RB1
Nguyen, PT1
Tsunematsu, T1
Yanagisawa, S1
Kudo, Y1
Miyauchi, M1
Kamata, N1
Takata, T1
Ezzat, S1
Zheng, L1
Winer, D1
Asa, SL1

Other Studies

3 other studies available for pd 173074 and Invasiveness, Neoplasm

ArticleYear
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.
    Oncogene, 2014, Jun-26, Volume: 33, Issue:26

    Topics: Aldehyde Dehydrogenase; Animals; Benzamides; Breast Neoplasms; Cadherins; Cell Movement; Cell Prolif

2014
The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1.
    British journal of cancer, 2013, Oct-15, Volume: 109, Issue:8

    Topics: Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Cell Nucleus; Epithelial-Mesenchy

2013
Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.
    Molecular endocrinology (Baltimore, Md.), 2006, Volume: 20, Issue:11

    Topics: Adenoma; Animals; Antineoplastic Agents; Brain Neoplasms; Cadherins; Cell Proliferation; Cells, Cult

2006